VIROLOGICAL RESPONSE AND SAFETY OF 4 WEEKS TREATMENT WITH THE PROTEASE INHIBITOR BI 201335 COMBINED WITH 48 WEEKS OF PEGINTERFERON ALFA 2A AND RIBAVIRIN FOR TREATMENT OF HCV GT-1 PATIENTS WHO FAILED PEGINTERFERON/RIBAVIRIN
HEPATOLOGY(2010)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要